Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

ATYR

aTYR PHARMA INC

Healthcare · Biotechnology

$0.38Sep 23, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

aTYR PHARMA INC shows stable business momentum based on AlphaOS pipeline evidence.

TrajectoryStable

3 signals not yet derived from pipeline evidence

Pipeline evidence · 0d ago

AlphaOS Signals
Upgrade to Premium

Latest Intelligence

Updated

What happened recently for aTYR PHARMA INC (ATYR) — events, not interpretation.

Event
Last session September 23, 2026 at $0.38.
Source
Market data

Research & analysis only — not investment advice.

Building company intelligence…

aTYR PHARMA INC (ATYR)

Healthcare · Biotechnology

Investment Snapshot above is the primary AlphaOS analysis for aTYR PHARMA INC — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Industry:
Biotechnology
Market cap:
$36.80M
Revenue:
$190,000

ATYR earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow aTYR PHARMA INC through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.